Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Recent health news highlights various developments, including Trump's spending bill impacting insurance costs, a major acquisition in the bioscience sector, and GSK's efforts to expand RSV vaccine ...

Qatar’s health care sector has undergone a profound transformation over the past decade, evolving into one of the most advanced systems in the GCC. Underpinned by Qatar National Vision (QNV) 2030, the ...

Inaugural 'Innovation Catalyst' event empowers innovators at UConn Health to transform their exciting research ideas into ...

Health and Human Services Secretary Robert F. Kennedy Jr. lambasted federal agencies he accused of being overly influenced by ...

Hemostats market was valued at US$ 2,884.13 million in 2024 and is projected to hit the market valuation of US$ 4,839.68 million by 2033 at a CAGR of 5.92% during the forecast period 2025–2033.

The country’s biggest pharmaceuticals group pointed to “specific non-allied countries” and urged the White House to ...

Overview of Contraceptive Drugs MarketThe global Contraceptive Drugs Market is valued at USD 19.80 Billion in 2024 and is projected to reach a value of USD 49.75 Billion by 2035 at a CAGR (Compound ...

Marc Filippino Like really big tariffs. Donald Trump voice clip If they have to bring the pharmaceuticals into the country, the drugs and other things into the country, they’re gonna be tariffed at a ...

Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...